BCMA- or GPRC5D-targeting bispecific antibodies in multiple myeloma: efficacy, safety, and resistance mechanisms
ow.ly/t21j50R4Asl #bloodspotlight #immunobiologyandimmunotherapy #lymphoidneoplasia #multiplemyeloma
“Treatment with curative intent”: the emergence of genetic therapies for sickle cell anemia
ow.ly/S3Aj50QTFLh #bloodspotlight #genetherapy #redcellsironanderythropoiesis
Recent developments in the use of pyruvate kinase activators as a new approach for treating sickle cell disease
ow.ly/CJzK50QNXwh #bloodspotlight #redcellsironanderythropoiesis #sicklecelldisease #SCD
CAR T-cell therapy in multiple myeloma: mission accomplished?
#BloodSpotlight #immunobiologyandimmunotherapy #lymphoidneoplasia #multiplemyeloma
